CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 59,666 enrolled
Drug / intervention
Vitamin A or Beta-Carotene Supplementsdietary
Likely dose
Vitamin A 7000 µg retinol equivalents weekly or beta-carotene 42 mg weeklyAI-extracted
Key inclusion· 2
  • Married women
  • First pregnancy during the trial period
Key exclusion· 6
  • Previous pregnancy history during trial enrollment
  • Premenarchial girls
  • Previously married women who have moved into study area
  • Single women (never married, widowers)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00198822
NCT00198822Phase 3Completed

Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh

Johns Hopkins Bloomberg School of Public Health·interventional·Posted Sep 20, 2005·Updated Mar 7, 2012

In Brief

A Phase 3 clinical trial evaluating Vitamin A or Beta-Carotene Supplements for Vitamin A Deficiency and 2 related conditions. Completed, enrolled 59,666 participants across 3 sites in 2 countries.

Detailed Summary

The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.

Study Details

Timeline

Phase 3CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 20, 2005
Enrollment StartAug 1, 2001
Primary CompletionJan 1, 2007
Study CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 20.8 years ago

Interventions

Vitamin A or Beta-Carotene Supplementsdietary

weekly dosage of either 7000 µg retinol equivalents as preformed vitamin A or 42 mg of beta-carotene from 1st trimester of pregnancy through 12 weeks after termination of pregnancy